Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.

Joubert M, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Jeandidier N, Penfornis A, Borot S, Chaillous L, Franc S, Serusclat P, Kherbachi Y, Bavière E, Detournay B, Simon P, Charpentier G.

J Diabetes Sci Technol. 2019 Mar 12:1932296819834054. doi: 10.1177/1932296819834054. [Epub ahead of print]

PMID:
30862245
2.

Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting.

Renard E, Tubiana-Rufi N, Bonnemaison-Gilbert E, Coutant R, Dalla-Vale F, Farret A, Poidvin A, Bouhours-Nouet N, Abettan C, Storey-London C, Donzeau A, Place J, Breton MD.

Diabetes Obes Metab. 2019 Jan;21(1):183-187. doi: 10.1111/dom.13482. Epub 2018 Aug 21.

PMID:
30047223
3.

DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial.

Jeandidier N, Chaillous L, Franc S, Benhamou PY, Schaepelynck P, Hanaire H, Catargi B, Farret A, Fontaine P, Guerci B, Reznik Y, Penfornis A, Borot S, Serusclat P, Kherbachi Y, D'Orsay G, Detournay B, Simon P, Charpentier G.

JMIR Res Protoc. 2018 Apr 19;7(4):e66. doi: 10.2196/resprot.9154.

4.

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.

Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, Charpentier G, Farret A, Filhol N, Franc S, Gouet D, Guerci B, Guilhem I, Guillot C, Jeandidier N, Joubert M, Melki V, Merlen E, Penfornis A, Picard S, Renard E, Reznik Y, Riveline JP, Rudoni S, Schaepelynck P, Sola-Gazagnes A, Tubiana-Rufi N, Verier-Mine O, Hanaire H; Société francophone du diabète (SFD), Société française d’endocrinologie (SFE); Évaluation dans le diabète des implants actifs Group (EVADIAC).

Diabetes Metab. 2018 Feb;44(1):61-72. doi: 10.1016/j.diabet.2017.10.009. Epub 2017 Nov 11.

PMID:
29174479
5.

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.

Dassau E, Renard E, Place J, Farret A, Pelletier MJ, Lee J, Huyett LM, Chakrabarty A, Doyle FJ 3rd, Zisser HC.

Diabetes Obes Metab. 2017 Dec;19(12):1698-1705. doi: 10.1111/dom.12999. Epub 2017 Jul 6.

6.

Improvement of Glucose Control and Reduction of Hypoglycemia Following Intravenous Immune Globulins in a Child With Type 1 Diabetes and High Levels of Insulin Antibodies.

Marchand L, Luigi P, Place J, Dalla-Vale F, Farret A, Renard E.

Diabetes Care. 2017 Jun;40(6):e69-e70. doi: 10.2337/dc16-2420. Epub 2017 Apr 6. No abstract available.

PMID:
28385685
7.

[The artificial pancreas, a dream on the point of becoming reality].

Renard É, Place J, Benbrahim N, Diouri O, Farret A.

Rev Infirm. 2017 Apr;66(230):35-37. doi: 10.1016/j.revinf.2017.02.010. French.

PMID:
28366258
8.

Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.

Marchand L, Kawasaki-Ogita Y, Place J, Fayolle C, Lauton D, Boulet F, Farret A, Renard E.

J Diabetes Sci Technol. 2017 Sep;11(5):924-929. doi: 10.1177/1932296817700161. Epub 2017 Mar 17.

9.

Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.

Kropff J, DeJong J, Del Favero S, Place J, Messori M, Coestier B, Farret A, Boscari F, Galasso S, Avogaro A, Bruttomesso D, Cobelli C, Renard E, Magni L, DeVries JH; AP@home consortium.

Diabet Med. 2017 Feb;34(2):262-271. doi: 10.1111/dme.13268. Epub 2016 Oct 28.

10.

Orthodontic camouflage of skeletal Class III malocclusion with miniplate: a case report.

Farret MM, Farret MM, Farret AM.

Dental Press J Orthod. 2016 Jul-Aug;21(4):89-98. doi: 10.1590/2177-6709.21.4.089-098.oar.

11.

Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.

Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, Visentin R, Calore R, Toffanin C, Di Palma F, Lanzola G, Magni P, Boscari F, Galasso S, Avogaro A, Keith-Hynes P, Kovatchev B, Del Favero S, Cobelli C, Magni L, DeVries JH; AP@home Consortium.

Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.

PMID:
27208331
12.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

13.

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.

Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M, Messori M, Di Palma F, Lanzola G, Farret A, Boscari F, Galasso S, Magni P, Avogaro A, Keith-Hynes P, Kovatchev BP, Bruttomesso D, Cobelli C, DeVries JH, Renard E, Magni L; AP@home consortium.

Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47. doi: 10.1016/S2213-8587(15)00335-6. Epub 2015 Sep 30.

PMID:
26432775
14.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.

Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, Monaro M, Galasso S, Boscari F, Toffanin C, Di Palma F, Lanzola G, Scarpellini S, Farret A, Kovatchev B, Avogaro A, Bruttomesso D, Magni L, DeVries JH, Cobelli C, Renard E; AP@home Consortium.

Diabetes Obes Metab. 2015 May;17(5):468-76. doi: 10.1111/dom.12440. Epub 2015 Feb 16.

PMID:
25600304
15.

Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions.

Kropff J, Bruttomesso D, Doll W, Farret A, Galasso S, Luijf YM, Mader JK, Place J, Boscari F, Pieber TR, Renard E, DeVries JH.

Diabetes Obes Metab. 2015 Apr;17(4):343-9. doi: 10.1111/dom.12378. Epub 2014 Sep 10.

16.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ 3rd, Lum J, Calhoun P, Kollman C, Dassau E, Farret A, Place J, Breton M, Anderson SM, Dalla Man C, Del Favero S, Bruttomesso D, Filippi A, Scotton R, Phillip M, Atlas E, Muller I, Miller S, Toffanin C, Raimondo DM, De Nicolao G, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):613-22. doi: 10.1089/dia.2014.0066. Epub 2014 Jul 8. Erratum in: Diabetes Technol Ther. 2015 Jan;17(1):68. Vistenin, Roberto [corrected to Visentin, Roberto].

17.

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd.

Diabetes Care. 2014 Jul;37(7):1789-96. doi: 10.2337/dc13-2076. Epub 2014 Jun 14.

18.

Assessment of Patient Perceptions About Web Telemonitoring Applied to Artificial Pancreas Use at Home.

Place J, Farret A, Del Favero S, Bruttomesso D, Renard E.

J Diabetes Sci Technol. 2014 Mar;8(2):225-229. Epub 2014 Mar 2.

19.

Preparation, characterization and in vitro thrombolytic activity of a novel streptokinase foam.

Farret AN, Azevedo EP, Raffin FN.

J Thromb Thrombolysis. 2014;38(2):176-82. doi: 10.1007/s11239-014-1070-9.

PMID:
24590503
20.

DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials.

Place J, Robert A, Ben Brahim N, Keith-Hynes P, Farret A, Pelletier MJ, Buckingham B, Breton M, Kovatchev B, Renard E.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1427-35.

21.

Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.

Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L; AP@home Consortium.

Diabetes Care. 2013 Dec;36(12):3882-7. doi: 10.2337/dc12-1956. Epub 2013 Oct 29.

22.

Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ 3rd.

Diabetes Care. 2013 Jul;36(7):1851-8. doi: 10.2337/dc12-1965.

23.

Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.

Luijf YM, Arnolds S, Avogaro A, Benesch C, Bruttomesso D, Farret A, Heinemann L, Place J, Renard E, Scotton R, DeVries JH; AP@home consortium.

Diabetes Technol Ther. 2013 Jul;15(7):575-9. doi: 10.1089/dia.2013.0016. Epub 2013 May 7.

24.

Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison.

Luijf YM, Mader JK, Doll W, Pieber T, Farret A, Place J, Renard E, Bruttomesso D, Filippi A, Avogaro A, Arnolds S, Benesch C, Heinemann L, DeVries JH; AP@home consortium.

Diabetes Technol Ther. 2013 Aug;15(8):722-7. doi: 10.1089/dia.2013.0049. Epub 2013 May 7.

25.

Unusual orthodontic approach to a maxillary canine-premolar transposition and a missing lateral incisor with long-term follow-up.

Farret MM, Farret MM, Farret AM, Hollweg H.

Am J Orthod Dentofacial Orthop. 2012 Nov;142(5):690-7. doi: 10.1016/j.ajodo.2011.03.027.

PMID:
23116510
26.

Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).

Chevassus H, Farret A, Gagnol JP, Ponçon CA, Costa F, Roux C, Galtier F, Petit P.

Eur J Clin Pharmacol. 2013 Apr;69(4):779-87. doi: 10.1007/s00228-012-1418-z. Epub 2012 Oct 9.

PMID:
23052417
27.

Skeletal Class III and anterior open bite treatment with different retention protocols: a report of three cases.

Farret MM, Farret MM, Farret AM.

J Orthod. 2012 Sep;39(3):212-23. doi: 10.1179/1465312512Z.00000000025.

PMID:
22984106
28.

Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes.

Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ 3rd, Patek SD, Avogaro A.

Diabetes Care. 2012 Sep;35(9):e65-7. doi: 10.2337/dc12-0660. No abstract available.

29.

Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers.

Galtier F, Mura T, Raynaud de Mauverger E, Chevassus H, Farret A, Gagnol JP, Costa F, Dupuy A, Petit P, Cristol JP, Mercier J, Lacampagne A.

Toxicol Appl Pharmacol. 2012 Sep 15;263(3):281-6. doi: 10.1016/j.taap.2012.06.020. Epub 2012 Jul 4.

PMID:
22771848
30.

Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group.

Diabetes. 2012 Sep;61(9):2230-7. Epub 2012 Jun 11.

31.

Towards an artificial pancreas at home.

Renard E, Farret A, Place J, Wojtusciszyn A, Bringer J.

Diabetes Metab. 2011 Dec;37 Suppl 4:S94-8. doi: 10.1016/S1262-3636(11)70973-9.

PMID:
22208718
32.

The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study).

Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A; TeleDiab Study Group.

Diabetes Care. 2011 Mar;34(3):533-9. doi: 10.2337/dc10-1259. Epub 2011 Jan 25.

33.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

34.

Infrared laser therapy after surgically assisted rapid palatal expansion to diminish pain and accelerate bone healing.

Abreu ME, Viegas VN, Pagnoncelli RM, de Lima EM, Farret AM, Kulczynski FZ, Farret MM.

World J Orthod. 2010 Fall;11(3):273-7.

PMID:
20877738
35.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

36.

Strategies to finish orthodontic treatment with a Class III molar relationship: three patient reports.

Farret MM, Farret MM, Farret AM.

World J Orthod. 2009 Winter;10(4):323-33.

PMID:
20072750
37.

A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.

Chevassus H, Gaillard JB, Farret A, Costa F, Gabillaud I, Mas E, Dupuy AM, Michel F, Cantié C, Renard E, Galtier F, Petit P.

Eur J Clin Pharmacol. 2010 May;66(5):449-55. doi: 10.1007/s00228-009-0770-0. Epub 2009 Dec 18.

38.

Selecting healthy volunteers in specific populations: a retrospective analysis of clinical and laboratory screening.

Roux C, Chevassus H, Farret A, Costa F, Petit P, Galtier F.

Fundam Clin Pharmacol. 2010 Feb;24(1):121-7. doi: 10.1111/j.1472-8206.2009.00727.x. Epub 2009 Aug 17.

PMID:
19686534
39.

The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice.

Léon C, Freund M, Latchoumanin O, Farret A, Petit P, Cazenave JP, Gachet C.

Purinergic Signal. 2005 Jun;1(2):145-51. doi: 10.1007/s11302-005-6209-x. Epub 2005 Mar 7.

40.

Direct rosiglitazone-induced modifications in insulin secretion, action and clearance: a single-dose hyperglycaemic clamp study.

Farret A, Chevassus H, Roux B, Petit P, Galtier F.

Diabetologia. 2007 Jul;50(7):1384-7. Epub 2007 May 8.

PMID:
17486315
41.

P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.

Farret A, Filhol R, Linck N, Manteghetti M, Vignon J, Gross R, Petit P.

Pharm Res. 2006 Nov;23(11):2665-71. Epub 2006 Oct 18.

PMID:
17048117
42.

Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost.

Galtier F, Farret A, Verdier R, Barbotte E, Nocca D, Fabre JM, Bringer J, Renard E.

Int J Obes (Lond). 2006 Jul;30(7):1104-10. Epub 2006 Feb 14.

PMID:
16477271
43.

Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.

Farret A, Lugo-Garcia L, Galtier F, Gross R, Petit P.

Fundam Clin Pharmacol. 2005 Dec;19(6):647-56. Review.

PMID:
16313276
44.

P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic beta-cell metabolism.

Farret A, Vignaud M, Dietz S, Vignon J, Petit P, Gross R.

Diabetes. 2004 Dec;53 Suppl 3:S63-6.

45.

Suprarenal aorta reconstruction using a saphenous spiral graft: case report.

Farret A, da Ros CT, Fischer CA, Mandelli JP, Farret Júnior LC.

J Trauma. 1994 Jul;37(1):114-8. Review.

PMID:
8028046

Supplemental Content

Loading ...
Support Center